Gloria Pérez-Rodríguez

5PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Microbial geneticsMedical infection agents (incl. prions)Medical bacteriologyMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Comparative activity of ceftibuten combinations with avibactam, ledaborbactam, and xeruborbactam against recombinant β-lactamase-producing Escherichia coli and contemporary WGS-characterized strains of carbapenemase-producing Enterobacterales.

|May 29, 2026
Genetic and biochemical characterization of OXA-1054, a carbapenem-hydrolyzing class D β-lactamase conferring broad-spectrum β-lactam resistance in Pseudomonas aeruginosa.

|Mar 27, 2026
Emergence of KPC-producing Pseudomonas aeruginosa in Spain: insights into an outbreak and resistance to the novel carbapenem/β-lactamase inhibitor combinations imipenem/relebactam and meropenem/vaborbactam.

Gloria Pérez-Rodríguez, Pablo Aja-Macaya, Lucía González-Pinto

|Oct 21, 2025
Contribution of mutational resistance mechanisms and acquired β-lactamases to cefiderocol/xeruborbactam susceptibility in Pseudomonas aeruginosa.

Lucía González-Pinto, María Antonia Gomis-Font, Gloria Pérez-Rodríguez

|Jul 25, 2025
Broad spectrum of β-lactamase coverage and potent antimicrobial activity of xeruborbactam in combination with meropenem against carbapenemase-producing Enterobacterales, including strains resistant to new β-lactam/β-lactamase inhibitor combinations.

Lucía Sánchez-Peña, Salud Rodríguez-Pallares, Pablo Aja-Macaya

Pageof 1

Frequent Collaborators

5 joint publications

Lucía Sánchez-Peña

5 joint publications

Salud Rodríguez-Pallares

5 joint publications

Tania Blanco-Martín

5 joint publications

Lucía González-Pinto